Wolf, Rasmus Trap http://orcid.org/0000-0002-0466-300X
Puggaard, Louise Berg
Pedersen, Mette Maria Agner
Pagsberg, Anne Katrine
Silverman, Wendy K.
Correll, Christoph U.
Plessen, Kerstin Jessica
Neumer, Simon-Peter
Gyrd-Hansen, Dorte
Thastum, Mikael
Bilenberg, Niels
Thomsen, Per Hove
Jeppesen, Pia
Funding for this research was provided by:
TrygFonden (-)
Lundbeckfonden (-)
Article History
Received: 23 February 2020
Accepted: 3 January 2021
First Online: 18 January 2021
Compliance with ethical standards
:
: RTW, LBP, MMAP, AKP, WKS, KJP, SPN, DGH, MT, NB, PHT and PJ declare that they have no conflict of interest. CUC has been a consultant and/or advisor to or has received honoraria from: Acadia, Alkermes, Allergan, Angelini, Axsome, Gedeon Richter, Gerson Lehrman Group, IntraCellular Therapies, Janssen/J&J, LB Pharma, Lundbeck, MedAvante-ProPhase, Medscape, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Sumitomo Dainippon, Sunovion, Supernus, Takeda, and Teva. He has provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck, Rovi, Supernus, and Teva. He received royalties from UpToDate and grant support from Janssen and Takeda. He is also a stock option holder of LB Pharma.
: Ethical approval of the Mind My Mind study was provided by the Regional Committee on Health Research Ethics in the Capital Region of Denmark, Journal-nr.: H-17011408.
: Participation was voluntary, and data was kept confidential. The parents gave written consent to the study participation. According to Danish legislation, individual informed consent or additional permission from the National Committee on Health Research Ethics is not required for registry-based studies. The parents gave written consent to the study participation.
: The written consent to the study participation included consent for publication.